Learning from Drops: AI-Guided Integration of Liquid Biopsy Features in Cancer Studies (opens in new tab)

Cancer is a major global health issue with rising incidence and mortality. Early detection, tumor characterization, and disease surveillance are crucial for timely and effective treatment, ultimately reducing mortality rates. Liquid biopsy (LB) has emerged as a valuable detection tool offering a non-invasive method to determine tumor-derived biomarkers in body fluids with demonstrated translational potential. To increase biomarker sensitivity, high-throughput sequencing platforms deliver mass...